Literature DB >> 7876335

Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.

K B Reddy1, B A Hocevar, P H Howe.   

Abstract

Transforming growth factor beta 1 (TGF beta 1) inhibits epithelial cell proliferation late in the G1 phase of the cell cycle. We examined the effect of TGF beta 1 on known late G1 cell cycle regulators in an attempt to determine the molecular mechanism of growth inhibition by this physiological inhibitor. The results demonstrate that TGF beta 1 inhibits the late G1 and S phase specific histone H1 kinase activity of p33cdk2. This inhibition is not due to TGF beta 1's effect on p33cdk2 synthesis, but rather due to its negative effects on the late G1 phosphorylation of p33cdk2. It is also shown that TGF beta inhibits both late G1 cyclin A and cyclin E associated histone H1 kinase activities. The inhibitor has no effects on the synthesis of cyclin E but is shown to inhibit the synthesis of cyclin A protein in a cell cycle dependent manner. If TGF beta 1 is added to cells which have progressed further than 8 hours into G1, then it is without inhibitory effect on cyclin A synthesis. These effects of TGF beta 1 on late G1 cell cycle regulators correlate well with its inhibitory effects on cellular growth and suggest that these G1 cyclin dependent kinases might serve as targets for TGF beta 1-mediated growth arrest.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876335     DOI: 10.1002/jcb.240560318

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.

Authors:  D Agrawal; P Hauser; F McPherson; F Dong; A Garcia; W J Pledger
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

Review 3.  Abrogation of transforming growth factor-beta signaling in pancreatic cancer.

Authors:  Xia Lin; Xin-Hua Feng
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.